Literature DB >> 15014725

A Case Report of Methylphenidate-Induced Dyskinesia.

Thomas W. Heinrich1.   

Abstract

Entities:  

Year:  2002        PMID： 15014725      PMCID： PMC315486          DOI： 10.4088/pcc.v04n0408a

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN： 1523-5998


× No keyword cloud information.
  5 in total

1.  A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa.

Authors:  O Rascol; D J Brooks; A D Korczyn; P P De Deyn; C E Clarke; A E Lang
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

2.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

3.  Methylphenidate-induced choreoathetosis.

Authors:  I Extein
Journal:  Am J Psychiatry       Date:  1978-02       Impact factor: 18.112

4.  Tics and dyskinesias associated with stimulant treatment in attention-deficit hyperactivity disorder.

Authors:  P H Lipkin; I J Goldstein; A R Adesman
Journal:  Arch Pediatr Adolesc Med       Date:  1994-08

5.  Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain.

Authors:  N D Volkow; G Wang; J S Fowler; J Logan; M Gerasimov; L Maynard; Y Ding; S J Gatley; A Gifford; D Franceschi
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167
  5 in total
  3 in total

1.  Neurological adverse effects of methylphenidate may be misdiagnosed as meningoencephalitis.

Authors:  Luke Blagdon Snell; Dinkar Bakshi
Journal:  BMJ Case Rep       Date:  2015-06-16

Review 2.  Psychostimulants and movement disorders.

Authors:  Andres Asser; Pille Taba
Journal:  Front Neurol       Date:  2015-04-20       Impact factor: 4.003

3.  Tardive Dyskinesia Associated with Bupropion.

Authors:  Taha Can Tuman; Uğur Çakır; Osman Yıldırım; Mehmet Akif Camkurt
Journal:  Clin Psychopharmacol Neurosci       Date:  2017-05-31       Impact factor: 2.582
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.